Stock Information
Aldeyra Therapeutics Inc (ALDX)
Ticker Symbol: ALDX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $327.03 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -0.38
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -53.14%
Latest News
-
Prime Medicine Stock Rallies Nearly 26% in a Month: Here's Why
Mon, Oct 12, 2026 3:24 PM
-
PMVP Stock Rises 19% in 3 Months: Here's What You Need to Know
Mon, Oct 12, 2026 2:55 PM
-
argenx Meets Primary Endpoint in Phase II Celiac Disease Study
Fri, Oct 9, 2026 4:55 PM
-
EDIT Set to Begin First-in-Human Study in Hypercholesterolemia
Fri, Oct 9, 2026 2:53 PM
-
Here's Why You Should Add LPCN Stock to Your Portfolio Now
Thu, Oct 8, 2026 1:57 PM
-
Ultragenyx to Sell Rare Pediatric Disease PRV for $210M to Boost Cash
Thu, Oct 8, 2026 1:49 PM
-
ETON Stock Surges 108% in Six Months: Here's What You Need to Know
Wed, Oct 7, 2026 3:08 PM
-
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tue, Oct 6, 2026 5:05 PM
-
AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know
Tue, Oct 6, 2026 1:55 PM
-
PCRX Expands Exparel Commercial Reach in Europe Through Molteni Deal
Tue, Oct 6, 2026 1:30 PM
Key Financials
Financial data not available